Skip to main content

Table 4 Reports of resource utilization in non-bleeding patients with IMC

From: Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety

Category

Count

%

Extended LOS

23

92.0%

Vit K

9

36.0%

FFP

8

32.0%

IVIG

5

20.0%

Plasmapheresis

5

20.0%

Steroids

4

16.0%

PLT

1

4.0%

Chemotherapy

0

0.0%

RBC

0

0.0%

  1. LOS – Length of stay; FFP – fresh frozen plasma; Vit K – vitamin K; IVIG – intravenous immune globulin; PLT – platelets; RBC – red blood cells
  2. Interventions among the 25 non-bleeding patients for whom case reports contained documentation of managing immune-mediated coagulopathy [3–5, 8, 9, 11, 12, 14, 15, 18, 21, 22, 24–26, 28–31, 35].
Back to article page

Patient Safety in Surgery

ISSN: 1754-9493